DF PHARMA SERVICES: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DF PHARMA SERVICES
Largest movements
- Cash +€1.2m
up €1.2m (+4,878%), from €24,162 to €1.2m
mainly Other debts (+€1.4m) and Investment in fixed assets (net) (+€1.0m)
- Financial fixed assets -€1.0m
down €1.0m (-67.1%), from €1.5m to €490,377
- Receivables within one year -€413,275
down €413,275 (-80.2%), from €515,371 to €102,096
of which Other amounts receivable: -€441,837
- Receivables after one year +€100,000
new in 2025: €100,000
- Reserves -€1.5m
down €1.5m (-88.4%), from €1.7m to €198,853
- Other debts +€1.4m
up €1.4m (+4,671%), from €30,600 to €1.5m
- Debts after one year -€31,623
down €31,623 (-12.1%), from €261,408 to €229,785
- Gross operating margin -€359,969
down €359,969, from €332,774 to -€27,195
- Financial income +€233,339
up €233,339 (+101,227%), from €231 to €233,569
of which Non-recurring financial income: +€200,000
- Taxes -€76,492
down €76,492 (-99.5%), from €76,862 to €370
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,090,622 | €1,957,639 | -€132,983 | -6.4% |
| Fixed assets | 21/28 | €1,491,983 | €491,364 | -€1.0m | -67.1% |
| Tangible fixed assets | 22/27 | €1,606 | €987 | -€619 | -38.5% |
| Plant, machinery and equipment | 23 | €645 | €273 | -€373 | -57.7% |
| Furniture and vehicles | 24 | €960 | €714 | -€246 | -25.6% |
| Financial fixed assets | 28 | €1,490,377 | €490,377 | -€1.0m | -67.1% |
| Current assets | 29/58 | €598,640 | €1,466,276 | +€867,636 | +145% |
| Amounts receivable after more than one year | 29 | - | €100,000 | +€100,000 | |
| Other amounts receivable | 291 | - | €100,000 | +€100,000 | |
| Amounts receivable within one year | 40/41 | €515,371 | €102,096 | -€413,275 | -80.2% |
| Trade receivables | 40 | €648 | €29,210 | +€28,562 | +4,408% |
| Other amounts receivable | 41 | €514,723 | €72,886 | -€441,837 | -85.8% |
| Current investments | 50/53 | €55,519 | €55,794 | +€275 | +0.5% |
| Cash at bank and in hand | 54/58 | €24,162 | €1,202,646 | +€1.2m | +4,878% |
| Deferred charges and accrued income | 490/1 | €3,588 | €5,740 | +€2,152 | +60.0% |
| Total equity and liabilities | 10/49 | €2,090,622 | €1,957,639 | -€132,983 | -6.4% |
| Equity | 10/15 | €1,736,149 | €217,453 | -€1.5m | -87.5% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,717,549 | €198,853 | -€1.5m | -88.4% |
| Distributable reserves | 133 | €1,717,549 | €198,853 | -€1.5m | -88.4% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €354,474 | €1,740,187 | +€1.4m | +391% |
| Amounts payable after more than one year | 17 | €261,408 | €229,785 | -€31,623 | -12.1% |
| Financial debts | 170/4 | €261,408 | €229,785 | -€31,623 | -12.1% |
| Amounts payable within one year | 42/48 | €88,337 | €1,505,198 | +€1.4m | +1,604% |
| Current portion of amounts payable after more than one year | 42 | €31,330 | €31,623 | +€293 | +0.9% |
| Financial debts | 43 | €9,029 | €10,115 | +€1,087 | +12.0% |
| Credit institutions | 430/8 | €9,029 | €10,115 | +€1,087 | +12.0% |
| Trade debts | 44 | €1,014 | €161 | -€854 | -84.1% |
| Suppliers | 440/4 | €1,014 | €161 | -€854 | -84.1% |
| Taxes, remuneration and social security | 45 | €16,363 | €3,365 | -€12,998 | -79.4% |
| Taxes | 450/3 | €16,363 | €3,365 | -€12,998 | -79.4% |
| Other amounts payable | 47/48 | €30,600 | €1,459,933 | +€1.4m | +4,671% |
| Accrued charges and deferred income | 492/3 | €4,729 | €5,204 | +€475 | +10.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €937 | €619 | -€318 | -34.0% |
| Other operating charges | 640/8 | €1,290 | €1,648 | +€358 | +27.8% |
| Gross operating margin | 9900 | €332,774 | -€27,195 | -€359,969 | |
| Operating profit (loss) | 9901 | €330,547 | -€29,462 | -€360,008 | |
| Financial income | 75/76B | €231 | €233,569 | +€233,339 | +101,227% |
| Recurring financial income | 75 | €231 | €33,569 | +€33,339 | +14,463% |
| Non-recurring financial income | 76B | - | €200,000 | +€200,000 | |
| Financial charges | 65/66B | €6,056 | €4,885 | -€1,171 | -19.3% |
| Recurring financial charges | 65 | €6,056 | €4,885 | -€1,171 | -19.3% |
| Profit (loss) for the period before taxes | 9903 | €324,721 | €199,222 | -€125,499 | -38.6% |
| Income taxes | 67/77 | €76,862 | €370 | -€76,492 | -99.5% |
| Profit (loss) for the period | 9904 | €247,859 | €198,853 | -€49,006 | -19.8% |
| Profit (loss) for the period to be appropriated | 9905 | €247,859 | €198,853 | -€49,006 | -19.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.